Patent · US Active

Systems and methods for treatment of urinary dysfunction

US9610442B2 · kind B2 · utility

63Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2016
Grant dateApr 4, 2017
Priority date
Expiry dateMay 20, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2/02
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and systems for providing therapy related to urological disorders which relate to stimulation of the saphenous nerve (SAFN) either alone or in combination with the posterior tibial nerve (PTN), medial plantar nerve (MPN) or lateral planar nerve. In embodiments nerves are stimulated by percutaneous, transcutaneous, and/or implanted stimulators. In embodiments the SAFN is stimulated below the level of the knee or near the medial malleolus. Embodiments also disclose improving nerve stimulation, including SAFN stimulation, using systems and methods termed enhanced transcutaneous electrical stimulation (eTENS) since these enhance the excitation of neural tissue. In an embodiment, systems and methods are provided to increase the chance of providing the selective modulation of specific (targeted) neural substrate, while decreasing the risk of activation of adjacent (non-targeted) nervous tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.